Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CGTX
#3362
Cognition Therapeutics, Inc. Common Stock
1.0
9
-5.22%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-5.22%
Monthly Change
-18.66%
6 month change
-58.87%
Year Change
+142.22%
Previous Close
1.1
5
Open
1.0
9
Bid
Ask
Low
1.0
9
High
1.0
9
Volume
16
Markets
US Stock Market
Healthcare
CGTX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
41.55 M
61.97 M
61.99 M
73.47 M
88.27 M
—
Valuation ratios
Enterprise value
-2.54 M
18.45 M
9.66 M
12.02 M
79.84 M
119.97 M
Price to earnings ratio
-0.49
-0.82
-0.59
-0.48
-3
-4.89
Price to sales ratio
-90.39
-142.89
—
—
—
—
Price to cash flow ratio
0.65
0.98
0.61
0.49
2.54
4.62
Price to book ratio
0.18
1.49
0.26
0.27
1.08
3.1
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.36
-0.26
-0.36
-0.34
-0.11
-1.08
Return on equity %
-0.69
-0.42
-0.69
-0.96
-0.13
-2.2
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.11
2.65
2.09
1.54
6.44
12.73
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.18
-0.21
-0.16
-0.09
-0.08
-0.54
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.58
0.63
0.27
0.17
0.58
1.65
Net current asset value per share
0.7
0.74
0.37
0.31
0.64
2.06
Tangible book value per share
0.38
0.47
0.2
0.11
0.54
1.32
Working capital per share
0.37
0.46
0.19
0.11
0.54
1.3
Book value per share
0.38
0.47
0.2
0.11
0.54
1.32
News
Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
Cognition’s DLB drug shows positive results in phase 2 trial
Cognition Therapeutics completes enrollment in expanded access program
Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
Cognition Therapeutics completes enrollment in Alzheimer’s drug trial
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?
Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone
These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025
Cognition Therapeutics closes $30 million registered direct offering
Cognition Therapeutics stock falls after $30 million direct offering